Mario Gabelli's NVO Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 4,144 shares of Novo Nordisk A/S (NVO) worth $229,951, representing 0.00% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in NVO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 4,544 shares. Largest reduction occurred in Q3 2016, reducing 12,352 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +17,150 | Add 0.00% | 17,140 | $15.52 |
| Q3 2013 | -100 | Reduce 0.58% | 17,040 | $16.90 |
| Q1 2014 | -1,710 | Reduce 10.04% | 15,330 | $22.83 |
| Q2 2014 | -90 | Reduce 0.59% | 15,240 | $23.10 |
| Q3 2014 | -1,800 | Reduce 11.81% | 13,440 | $23.81 |
| Q1 2015 | -40 | Reduce 0.30% | 13,400 | $26.72 |
| Q2 2015 | -310 | Reduce 2.31% | 13,090 | $27.35 |
| Q3 2015 | -750 | Reduce 5.73% | 12,340 | $27.15 |
| Q4 2015 | +80 | Add 0.65% | 12,420 | $29.07 |
| Q1 2016 | +30 | Add 0.24% | 12,450 | $27.07 |
| Q2 2016 | -98 | Reduce 0.79% | 12,352 | $26.88 |
| Q3 2016 | -12,352 | Sold Out | 0 | $0.00 |
| Q4 2022 | +2,968 | New Buy | 2,968 | $67.67 |
| Q2 2023 | -2,968 | Sold Out | 0 | $0.00 |
| Q2 2025 | +4,544 | New Buy | 4,544 | $69.02 |
| Q3 2025 | -400 | Reduce 8.80% | 4,144 | $55.49 |
Mario Gabelli's Novo Nordisk A/S Investment FAQs
Mario Gabelli first purchased Novo Nordisk A/S (NVO) in Q2 2013, acquiring 17,140 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Novo Nordisk A/S (NVO) for 19 quarters since Q2 2013.
Mario Gabelli's largest addition to Novo Nordisk A/S (NVO) was in Q2 2013, adding 17,140 shares worth $266,000.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 4,144 shares of Novo Nordisk A/S (NVO), valued at approximately $229,951.
As of the Q3 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Novo Nordisk A/S (NVO) was 17,140 shares, as reported at the end of Q2 2013.